Cargando…
Electrocardiographic Effects of a Supratherapeutic Dose of WCK 2349, a Benzoquinolizine Fluoroquinolone
The purpose of this study was to measure the electrocardiographic (ECG) effects of WCK 2349 (the L‐alanine ester prodrug of levonadifloxacin) at a supratherapeutic oral dose of 2,600 mg. A total of 48 healthy volunteers were randomized to treatment with placebo, WCK 2349, or oral moxifloxacin, 400 m...
Autores principales: | Mason, Jay W., Chugh, Rakesh, Patel, Anasuya, Gutte, Ranjeet, Bhatia, Ashima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342240/ https://www.ncbi.nlm.nih.gov/pubmed/30369076 http://dx.doi.org/10.1111/cts.12594 |
Ejemplares similares
-
In Vitro activity of a Novel Benzoquinolizine Antibiotic, Levonadifloxacin (WCK 771) against Blood Stream Gram-Positive Isolates from a Tertiary Care Hospital
por: Mamtora, Dhruv, et al.
Publicado: (2020) -
Levonadifloxacin, a Novel Broad-Spectrum Anti-MRSA Benzoquinolizine Quinolone Agent: Review of Current Evidence
por: Bhagwat, Sachin S, et al.
Publicado: (2019) -
HPLC Method for Determination of Enantiomeric Purity of a Novel Respiratory Fluoroquinolone: WCK 1152
por: Yeole, R. D., et al.
Publicado: (2008) -
An evaluation of a supratherapeutic dose of inclisiran on cardiac repolarization in healthy volunteers: A phase I, randomized study
por: Kallend, David, et al.
Publicado: (2022) -
Efficient Synthesis of Potential Impurities in Levonadifloxacin
(WCK 771)
por: Kilbile, Jaydeo T., et al.
Publicado: (2021)